Science
Mechanism of Action
While the specific mechanism of action for MINOXIDIL OXOTHIAZOLIDINECARBOXYLATE lacks detailed description, its parent compound, Minoxidil, is known to operate by engaging adenosine triphosphate (ATP)-sensitive potassium channels within cell membranes. This activity stimulates localized microcirculation around hair follicles, induces arteriolar vasodilation, and extends the anagen (growth) phase while shortening the telogen (resting) phase of hair, alongside potential induction of vascular endothelial growth factor (VEGF) expression.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Stability
Specific stability insights for MINOXIDIL OXOTHIAZOLIDINECARBOXYLATE are not available. For the parent compound, Minoxidil, formulations at concentrations between 2% and 15% have demonstrated stability for at least 180 days in a FOAMIL base under ambient conditions, maintaining pH and physical integrity. Minoxidil formulations are generally stable within pH ranges of 5.0-8.0, with stability also noted around pH 4.5.
Safety
Safety Profile
MINOXIDIL OXOTHIAZOLIDINECARBOXYLATE carries significant regulatory restrictions, being classified as 'Regulated, Forbidden in Europe' and receiving a 'Strong penalty' across all categories by COSMILE Europe and INCI Beauty. No specific FDA approval for this derivative has been identified, differentiating it from the FDA-approved status of Minoxidil for topical hair loss treatments.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Due to a lack of specific clinical efficacy data for MINOXIDIL OXOTHIAZOLIDINECARBOXYLATE, its classification as 'Forbidden in Europe,' and reported high irritancy, its inclusion in precision skincare formulations is strongly advised against.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources